<SUBMISSION>
<SECRELEASE-DATETIME> 20230428-105555 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20230428-105555 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20230428-105538 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001437749-23-011527
<TYPE> 424B5
<PUBLIC-DOCUMENT-COUNT> 3
<FILING-DATE> 20230428
<DATE-OF-FILING-DATE-CHANGE> 20230428
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> NAVIDEA BIOPHARMACEUTICALS, INC.
<CIK> 0000810509
<ASSIGNED-SIC> 2835
<IRS-NUMBER> 311080091 ⇒ 31-1080091 or 311-08-0091
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> 424B5
<ACT> 33
<FILE-NUMBER> 333-252847
<FILM-NUMBER> 23861680
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 4995 BRADENTON AVENUE
<STREET2> SUITE 240
<CITY> DUBLIN
<STATE> OH
<ZIP> 43017
<PHONE> 6147937500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 4995 BRADENTON AVENUE
<STREET2> SUITE 240
<CITY> DUBLIN
<STATE> OH
<ZIP> 43017
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> NEOPROBE CORP
<DATE-CHANGED> 19940714
</FORMER-COMPANY>
</FILER>
|
<DOCUMENT>
<TYPE> 424B5
<SEQUENCE> 1
<FILENAME> navb20230427_424b5.htm
<DESCRIPTION> FORM 424B5
<TEXT>
<html>
Show <HTML>: 6,352 lines (widest: 3,857 characters) - 540K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 2 ⇐ Not a Document/Exhibit
<FILENAME> navb20210207_s3img001.jpg
<TEXT>
Show <TEXT>: 82 lines (Unix-to-Unix encoding) - 5K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 3 ⇐ Not a Document/Exhibit
<FILENAME> navb20230427_424b5img001.jpg
<TEXT>
Show <TEXT>: 98 lines (Unix-to-Unix encoding) - 6K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
